NextDose is a free web-based dose calculator positioned for individualized dosing based on drug concentrations. It uses Bayesian forecasting and a target concentration intervention approach, and supports a wide range of drugs including busulfan, methotrexate, tacrolimus, warfarin, linezolid, voriconazole, gentamicin, vancomycin, dabigatran, clozapine, and enoxaparin. Strictly speaking, it is not a typical developer tool, but rather a specialized web application for clinical pharmacokinetics/pharmacodynamics and therapeutic drug monitoring scenarios.
Based on the main content, NextDoseβs core capability is dose prediction using observed drug concentration or pharmacodynamic values, with ongoing maintenance of models for different drugs. Recent versions, for example, mention that the busulfan model can estimate lag time caused by infusion dead volume, while also improving oral absorption lag time and bioavailability parameters. It has also fixed issues related to dabigatran oral bioavailability covariates and Csstrough reporting. The system supports registered single-user access, and users can apply to share patient data within a secure group. The main text does not disclose any API, SDK, data formats, hospital system integrations, third-party ecosystem, or self-hosting capabilities.
The page explicitly describes it as a free web-based dose calculator, and anyone can register for single-user access. No paid plans, enterprise edition, payment methods, or usage limits were found. This makes it highly cost-effective, but information on payments and commercial support is absent. There is no evidence in the source text about access from mainland China, so this should be marked as unknown. If used within a medical institution, users should independently assess network connectivity, privacy terms, cross-border patient data transfer, and compliance requirements.
Its advantages are that it is free, web-based, covers a relatively broad range of drugs, and has a fairly transparent changelog. It even publicly documents an FSTREAM error that once caused all calculation results to fail due to insufficient testing, along with the fix process. This level of transparency is valuable, but it also reveals risks around stability and testing procedures. In terms of documentation, the captured content mainly consists of an introduction, login/registration information, and release notes, while lacking a complete user guide, model validation details, API documentation, and compliance information. It is better suited for clinical pharmacists, physicians, and pharmacokinetics researchers as an auxiliary calculation tool, and is not suitable for automated integration into critical clinical workflows without professional review.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on nextdose.org official site.
nextdose.org is an Australia Dev Tools provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach nextdose.org directly.